Loading…
View analytic
Monday, June 19 • 11:00am - 12:15pm
#123: Calling All Angels to the Valley of Death

Sign up or log in to save this to your schedule and see who's attending!

Tweet Share
Component Type: Forum
Level: Intermediate
CE: CME 1.25; IACET 1.25; RN 1.25

The Valley of Death refers to the obstacles that are keeping innovative medical research discoveries from becoming new therapies or even making it to clinical trials.  Funding is necessary to bridge the gap.  This session will provide insight into strategies used by translational research scientists and funding agencies to expedite the transformation of basic research into break through clinical applications.

Learning Objectives

Describe strategies used to expedite the transformation of basic research into breakthrough clinical applications.

Chair

David Vulcano, MBA

Speaker

What Angel Investors Think About Medical Product Investing
David Vulcano, MBA

NCATS Small Business Opportunities
Christine Colvis, PhD

Panelist
Ginger A Spitzer, MA


Moderators
avatar for David Vulcano

David Vulcano

Vice President, Clinical Research Compliance & Integrity, Hospital Corporation of America (HCA)
David is a well-known leader in the clinical research industry through numerous associations, boards and initiatives. Among other things he is currently employed by HCA, the largest private healthcare provider in the United States, as the Responsible Executive for Clinical Research... Read More →

Speakers
avatar for Christine Colvis

Christine Colvis

Director, Drug Development Partnership Programs, National Center for Advancing Translational Sciences (NCATS)
Christine Colvis joined NCATS in June 2012 as the Center’s director of drug development partnership programs. Her team is best known for leading the Discovering New Therapeutic Uses for Existing Molecules (New Therapeutic Uses) program, which supports pre-clinical and clinical research... Read More →
GS

Ginger Spitzer

Executive Director, Foundation of Sarcoidosis Research
Virginia "Ginger" Spitzer leads the strategic plan to support the FSR mission and to build resources. With a strong background in non-profit management, Ginger holds expertise in organizational growth, operations, and funder relations. With over 25 years of experience in the field... Read More →
avatar for David Vulcano

David Vulcano

Vice President, Clinical Research Compliance & Integrity, Hospital Corporation of America (HCA)
David is a well-known leader in the clinical research industry through numerous associations, boards and initiatives. Among other things he is currently employed by HCA, the largest private healthcare provider in the United States, as the Responsible Executive for Clinical Research... Read More →

Monday June 19, 2017 11:00am - 12:15pm
S405b McCormick Place 2301 South Martin Luther King Jr. Drive, Gate 4 Chicago, IL 60616
  09: TranslSci-Preclin-Clin-ProdDev, Forum